Fluocinolone acetonide vitreous insert for chronic diabetic macular oedema: a systematic review with meta-analysis of real-world experience
Abstract We conducted a meta-analysis of real-world studies on the 0.19 mg Fluocinolone Acetonide (FAc) intravitreal implant for chronic diabetic macular oedema (DMO), comparing these findings with the Fluocinolone Acetonide for Diabetic Macular Edema (FAME) study. The primary outcome was mean chang...
Guardado en:
Autores principales: | Matteo Fallico, Andrea Maugeri, Andrew Lotery, Antonio Longo, Vincenza Bonfiglio, Andrea Russo, Teresio Avitabile, Claudio Furino, Gilda Cennamo, Martina Barchitta, Antonella Agodi, Paola Marolo, Luca Ventre, Paolo Caselgrandi, Michele Reibaldi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e4a5ce518fe424c879b866e62d312c0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fluocinolone acetonide and its potential in the treatment of chronic diabetic macular edema
por: Haritoglou C, et al.
Publicado: (2013) -
Applying a hierarchical clustering on principal components approach to identify different patterns of the SARS-CoV-2 epidemic across Italian regions
por: Andrea Maugeri, et al.
Publicado: (2021) -
Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant
por: Sheppard Jr JD, et al.
Publicado: (2012) -
Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in CAPN5-associated proliferative vitreoretinopathy
por: Tlucek PS, et al.
Publicado: (2013) -
Ahmed glaucoma valve in uveitic patients with fluocinolone acetonide implant-induced glaucoma: 3-year follow-up
por: Kubaisi B, et al.
Publicado: (2018)